Abiopharma

Clinical trial NCT04780009 updates: 1. completion date: 2026-06-01 → 2027-08-01 2. primary completion date: 2026-06-01 → 2027-08-01

Clinical trial NCT06520072 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2024-11-19 3. primary completion date: 2025-12-01 → 2024-11-19 4. enrollment: 1200 → 224 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05111925 updates: 1. completion date: 2025-05-31 → 2028-05-31 2. primary completion date: 2025-05-31 → 2027-05-31

Clinical trial NCT07587697 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 30 → 15 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07586618 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-06-01

In his letter to shareholders, CEO of Tonner Drones discusses SpaceX, the turnaround of the company, and the future

Coupang Jumps to No. 132 on Fortune 500® as the Company Scales AI-Driven Global Commerce

ModelFront Announces Outcome-Based Pricing

C.H. Robinson Launches Worlds First AI Technology That Continually Assesses, Improves and Operates Global Supply Chains

Dans sa lettre aux actionnaires, le PDG de Tonner Drones évoque SpaceX, le redressement de lentreprise et lavenir